Development of Insulin Resistance by Nitrate Tolerance in Conscious Rabbits

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 3, 2004, Pages 471-476

  Bajza, Agnes ^a   Peitl, Barna ^a   Nemeth, Jozsef ^b   Porszasz, Robert ^a   Rabloczky, Gyorgy ^c   Literati Nagy, Peter ^c   Szilvassy, Judith ^a   Szilvassy, Zoltan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c N Gene Research Laboratories   (Hungary)

Author keywords

3 morpholinosydnonimine; Insulin resistance; Nitrate tolerance; Nitric oxide; Nitric oxide donor; Nitroglycerin

Indexed keywords

GLUCOSE; GLYCERYL TRINITRATE; INSULIN; LINSIDOMINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRODERM TTS 5; PLACEBO;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONSCIOUSNESS; CONTROLLED STUDY; DRUG TOLERANCE; GLUCOSE CLAMP TECHNIQUE; HEMODYNAMICS; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; TRANSDERMAL PATCH;

ANIMALS; BLOOD PRESSURE; DRUG TOLERANCE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; INSULIN RESISTANCE; MALE; NITRATES; NITRIC OXIDE DONORS; NITROGLYCERIN; RABBITS; VASODILATOR AGENTS;

EID: 1442276968     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200403000-00020     Document Type: Article

References (26)

1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
2. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
3. Garthwaite J. Neural nitric oxide signalling. Trends Neurosci. 1995;18:51-52.
4. Sadri P, Legare DJ, Lautt WW. Insulin resistance caused by nitric oxide synthase inhibition. Proc West Pharmacol Soc. 1997;40:19-20.
5. Lautt WW. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol. 1999;77:553-562.
6. Kovacs P, Szilvassy Z, Hegyi P, et al. Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers. Eur J Clin Invest. 2000;30:41-44.
7. Shankar RR, Zhu JS, Ladd B, et al. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest. 1998;102:1403-1412.
8. Shankar RR, Wu Y, Shen H, et al. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes. 2000;49:684-687.
9. Parker JD, Parker JO. Nitrate therapy for stable anginapectoris. N Engl J Med. 1998;338:520-531.
10. Szilvássy Z, Ferdinandy P, Bor P, et al. Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin. Br J Pharmacol. 1994;112:999-1001.
11. Ferdinandy P, Szilvassy Z, Csont T, et al. Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol. 1995;115:1129-1131.
12. Sari R, Szilvassy Z, Jakab I, et al. Cross tolerance between nitroglycerin and neural relaxation of the sphincter of Oddi. Pharmacol Res. 1998;37:505-512.
13. Gilbert M, Basile S, Baudelin A, et al. Lowering plasma free fatty acid levels improve ionsulin action in conscious pregnant rabbits. Am J Physiol. 1993;264:E576-E582.
14. Mossberg KA, Taegtmeyer H. Time course of skeletal muscle glucose uptake during euglycaemic hyperinsulinaemia in anaesthetized rabbit: a fluorine-18-2-deoxy-2-fluoro-D-glucose study. J Nucl Med. 1992;33:1523-1529.
15. Szilvassy Z, Ferdinandy P, Nagy I, et al. The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol. 1997;121:491-496.
16. Szilvassy Z, Ferdinandy P, Szilvassy J, et al. Loss of preconditioning in atherosclerotic rabbits: The role of hypercholesterolaemia. J Mol Cell Cardiol. 1995;27:2559-2569.
17. Defronzo RA, Tobin JD, Andres RA. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
18. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
19. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
20. Csont T, Szilvassy Z, Fulop F, et al. Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol. 1999;128:1427-1434.
21. Ferdinandy P, Csont T, Csonka C, et al. Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP? Naunyn Schmiedebergs Arch Pharmacol. 1997;356:356-363.
22. Oroszi G, Szilvassy Z, Nemeth J, et al. Interplay between nitric oxide and CGRP by capsaicin in isolated guinea-pig heart. Pharmacol Res. 1999;40:125-128.
23. Oroszi G, Szilvassy Z, Nemeth J, et al. Interaction between capsaicin and nitrate tolerance in isolated guinea pig heart. Eur J Pharmacol. 1999;368:R1-R3.
24. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: parallels between human disease and rodent models. Diabetes Care. 1991;14:195-202.
25. Piatti PM, Monti LD, Zavaroni I, et al. Alterations in nitric oxide/cyclic GMP pathway in nondiabetic siblings of patients with type 2 diabetes. J Clin Endocrinol Metab. 2000;85:2416-2420.
26. McGowder D, Ragoobirsingh D, Dasgupta T. The hyperglycemic effect of S-nitrosoglutathione in the dog. Nitric Oxide. 1999;3:481-491.